Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Stem Cell Therapy Market Grown from 2024 to 2025?

In recent times, the market size of stem cell therapy has experienced quick expansion. The size is forecasted to increase from $7.86 billion in 2024 to $9.26 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 17.7%. This notable growth during the historical period is due to several key elements, such as the escalating prevalence of chronic illnesses, intensifying funding support from government and private entities, the rapid growth of upcoming markets, rising investments in cell and gene treatments, a boost in healthcare spends, and an augment in expenditure on pharmaceutical R&D.

What Growth Rate Is Anticipated for the Stem Cell Therapy Market in the Coming Years?

The market for stem cell therapy is predicted to experience a rapid surge in size in the coming years, projected to reach $14.6 billion by 2029, with a compound annual growth rate (CAGR) of 12.1%. This projected growth within the forecast period can be tied to a number of contributing factors, including burgeoning support from the government, a swift increase in the elderly population, a uptick in research and development expenditures, and a rise in healthcare spending. The forecast period will likely see several key trends; an emphasis on closely observing advancements in mesenchymal stem cell therapy with the aim of reaping benefits from field innovations, collaborations and acquisition of other firms by market players to bolster product innovation and increase revenue, companies should ponder on investing in developing ipsc-derived nk cells for patient treatment, a focus on stem cell therapy development by firms operating in this market specifically for cancer treatment as a way to secure a competitive edge against somatic cell rivals, and the implementation of artificial intelligence by companies in the stem cell therapy market to enhance product quality, safety and manufacturing efficiency.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Who Are the Leading Companies in the Stem Cell Therapy Market?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

What Are the Key Drivers of the Stem Cell Therapy Market?

The increasing occurrence of chronic illnesses is aiding the expansion of the stem cell therapy market. Extended work hours, lack of physical exercise, and unhealthy consumption habits are the factors contributing to the prevalence of chronic diseases, thus enhancing the need for stem cell therapy. A United Nations article predicts that by 2030, chronic diseases will account for 70% of all deaths globally. The global implication of chronic diseases is predicted to reach approximately 60%. Thus, the increasing prevalence of chronic illnesses is anticipated to propel the growth of the stem cell therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

What Are the Key Market Segments in the Stem Cell Therapy Industry?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

What Are the Latest Trends in the Stem Cell Therapy Market?

Strategic partnerships are gaining momentum among firms within the stem cell therapy market. This type of collaboration, often non-competitive, is mutually beneficial to both companies involved. As an example, SQZ Biotechnologies, a biotech firm from the United States, formed a strategic alliance with Canada’s STEMCELL Technologies Inc. in May 2022. Together, they aim to develop and bring to market a research-only microfluidic intracellular delivery system based on SQZ’s proprietary Cell Squeeze technology. This will give the life sciences sector enhanced cell engineering potential for use in preclinical studies. The two businesses will publish important data revealing the RUO system’s potential to deliver cargoes efficiently to primary immune cells and highlight advancements in cell engineering using mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

What Are the Key Regional Markets in the Stem Cell Therapy Industry?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

This Report Delivers Insight On:

1. How big is the stem cell therapy market, and how is it changing globally?

2. Who are the major companies in the stem cell therapy market, and how are they performing?

3. What are the key opportunities and risks in the stem cell therapy market right now?

4. Which products or customer segments are growing the most in the stem cell therapy market?

5. What factors are helping or slowing down the growth of the stem cell therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model